BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Staging
4 results:

  • 1. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
    Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
    Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. 124I-PET/CT images of differentiated thyroid cancer patients. Distinguishing lymph node metastases from thyroid remnants using kinetic quantities.
    Rosenbaum-Krumme S; Nagarajah J; Ruhlmann M; Bockisch A; Jentzen W
    Nuklearmedizin; 2012; 51(6):213-6. PubMed ID: 22892653
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Expression of GLUT-1, p63 and DNA-Pkcs in serous ovarian tumors and their significance].
    Shao SL; Cai Y; Wang QH; Yan LJ; Zhao XY; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):697-700. PubMed ID: 18246802
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
    Hornick JL; Lauwers GY; Odze RD
    Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.